Kyle and Manetsch Receive New R01 from NIAID for Antimalarial Drug Discovery
Dr. Dennis Kyle (Global Health) and Dr. Roman Manetsch (Chemistry) have been awarded a new multiple PI five year R01 from the National Institute of Allergy and Infectious Diseases (NIAID). The project entitled “Validation of New Antimalarial Leads” was awarded under the RFA for NIAID Partnerships with Product Development Public-Private Partnerships. The total award of $6.2 M has been made to a consortium including PIs Kyle and Manetsch at USF, Dr David Waterson at the Medicines for Malaria Venture (Geneva, Switzerland), Dr. Kip Guy at St Jude’s Children’s Research Hospital, […]